M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The transcytotic capability and expression of distinct carbohydrate receptors on the intestinal M-cells render it a potential portal for the targeted oral vaccine delivery. PLGA nanoparticles loaded with HBsAg were developed and antigen was stabilized by co-encapsulation of trehalose and Mg(OH)(2). Additionally, Ulex europaeus 1 (UEA-1) lectin was anchored to the nanoparticles to target them to M-cells of the peye's patches. The developed systems was characterized for shape, size, polydispersity index and loading efficiency. Bovine submaxillary mucin (BSM) was used as a biological model for the in vitro determination of lectin activity and specificity. The targeting potential of the lectinized nanoparticles were determined by Confocal Laser Scanning Microscopy (CLSM) using dual staining technique. The immune stimulating potential was determined by measuring the anti-HBsAg titre in the serum of Balb/c mice orally immunized with various lectinized formulations and immune response was compared with the alum-HBsAg given intramuscularly. Induction of the mucosal immunity was assessed by estimating secretary IgA (sIgA) level in the salivary, intestinal and vaginal secretion. Additionally, cytokines (interleukin-2; IL-2 and interferon-gamma; IFN-gamma) level in the spleen homogenates was also determined. The results suggest that HBsAg can be successfully stabilized by co-encapsulation of protein stabilizers. The lectinized nanoparticles have demonstrated approximately 4-fold increase in the degree of interaction with the BSM as compared to plain nanoparticles and sugar specificity of the lectinized nanoparticles was also maintained. CLSM showed that lectinized nanoparticles were predominantly associated to M-cells. The serum anti-HBsAg titre obtained after oral immunization with HBsAg loaded stabilized lectinized nanoparticles was comparable with the titre recorded after alum-HBsAg given intramuscularly. The stabilized UEA-1 coupled nanopartilces exhibited enhanced immune response as compared to stabilized non-lectinized nanoparticles. Furthermore, the stabilized lectinized nanoparticles elicited sIgA in the mucosal secretion and IL-2 and IFN-gamma in the spleen homogenates. These stabilized lectinized nanoparticles could be a promising carrier-adjuvant for the targeted oral-mucosal immunization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These NPs were shown to specifically bind via α-l-fucose to mouse M cells ex vivo.”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [113]
In the citing paper
“After three oral immunizations with UEA-I coated, HBsAg loaded NPs and a booster immunization after 3 weeks, mice developed HBsAg-specific serum antibody titers comparable to levels measured after intramuscular injection of HBsAg adsorbed to aluminum hydroxide.”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [113]
In the citing paper
“Furthermore, gavages of these UEA-I coated NPs-induced mucosal secretion of sIgA and the production of IL-2 and IFN-γ in spleens, indicating a Th1-dominant immune response [113].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [113]
In the citing paper
“lectins binding to the M-cell glycocalyx may serve as specific targeters on carrier systems for antigen or drug delivery to the immune system [9,13–15].”
From Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy (2018) · cites this paper as [14]
Citations
Cites
Sahoo, S. K., Panyam, J., Prabha, S., & Labhasetwar, V. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00127-x · Cited by 990
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
Deres, K., Schild, H., Wiesmüller, K.-H., Jung, G., & Rammensee, H.-G. (1989) · Nature · doi:10.1038/342561a0 · Cited by 631
Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
Zhu, G., Mallery, S. R., & Schwendeman, S. P. (2000) · Nature Biotechnology · doi:10.1038/71916 · Cited by 609
Oral Microbial Ecology and the Role of Salivary Immunoglobulin A
Marcotte, H., & Lavoie, M. C. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.71-109.1998 · Cited by 588
The Cell Biology of Antigen Processing and Presentation
Brodsky, F. M., & Guagliardi, L. E. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.003423 · Cited by 348
Strategies for designing and optimizing new generation vaccines
Berzofsky, J. A., Ahlers, J. D., & Belyakov, I. M. (2001) · Nature Reviews Immunology · doi:10.1038/35105075 · Cited by 334
Gutierro, I., Hernández, R. M., Igartua, M., Gascón, A. R., & Pedraz, J. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00435-8 · Cited by 292
Cleland, J. L., & Jones, A. J. S. (1996) · Pharmaceutical Research · doi:10.1023/a:1016063109373 · Cited by 266
Sansonetti, P. J., & Phalipon, A. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0175 · Cited by 266
A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions
Elson, C. O., Ealding, W., & Lefkowitz, J. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90089-9 · Cited by 224
Research works printed but not linked: 1
- Vyas SP, 2001, Pharmazie, 56, 554
Cited by
Current advances in research and clinical applications of PLGA-based nanotechnology
Lü, J.-M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.15 · Cited by 903
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
Current state and challenges in developing oral vaccines
Vela Ramirez, J. E., Sharpe, L. A., & Peppas, N. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.008 · Cited by 412
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
Metadata
- Authors
- Gupta, P. N., Khatri, K., Goyal, A. K., Mishra, N., & Vyas, S. P.
- Affiliations
- Dr. Hari Singh Gour University (IN)
- Venue
- Journal of Drug Targeting
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 15
- Issue
- 10
- Pages
- 701-713
- ISSN
- 1026-7158 (ISSN-L)
- 1061-186X
- 1029-2330
- OpenAlex
- W2167878693
- Cited by
- 136
- References
- 43
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 8 · 2019: 4 · 2018: 10 · 2017: 6 · 2016: 13 · 2015: 10 · 2014: 12 · 2013: 6 · 2012: 10
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of drug targeting (publishedVersion)
- PubMed (publishedVersion)
- Funders
- All India Council for Technical Education
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- M cells, oral vaccine delivery, hepatitis B, hepatitis B surface antigen, PLGA nanoparticles, trehalose, magnesium hydroxide, protein stabilization, Peyer's patches, mucosal immunity, secretory IgA, cytokine response, adjuvants, oral immunization
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Administration, Oral, Animals, Female, Immunoglobulin A, Secretory, Immunization, Interferon-gamma, Interleukin-2, Intestinal Mucosa, Mice, Inbred BALB C, Polyglycolic Acid, Polymers, Hepatitis B Vaccines, Lactic Acid, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. https://app.cochat.ai/papers/10.1080/10611860701637982
- The paper
- Gupta, P. N., Khatri, K., Goyal, A. K., Mishra, N., & Vyas, S. P. (2007). M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. Journal of Drug Targeting. https://doi.org/10.1080/10611860701637982
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.